Replies to post #112083 on Avid Bioservices Inc (CDMO)

[exwannabe]

FTM, a question for you.

Do you suspect that the delayed effect is "the" issue that is responsible for lack of a clear win in P2 trials?

If so, seams like kind of a bitch of a problem. Generally smaller biotechs are forced to run trials in sicker populations for cash reasons. But if one presumes a drug that is delayed and/or acts against smaller tumour masses, then these are the worst trials to run.

So how to break out of the trap?

[Seagull2]

FTM, do you think that PPHM will continue to pursue their Trials in the stage IV Pancreatic Cancer arena after the conclusion of their latest trials. What do you think will be the Co's next path forward in this arena. Is it likely that they could achieve better results by trying Bavi in different combinations with other drugs to try and treat this indication. According to all the data compiled to date the upcoming news that we should be receiving soon on 2nd Line NSCLC should vindicate BAVI and show that it is the first in class drug that RG and the Rest of the Company's executives believe. Considering the release of yesterday's news do you still believe that we will be seeing higher stock prices over the next six weeks. I still believe that the good news will be coming, if not tommorrow, by the end of next week, and that PPS will be much higher at that point. Do you still stand by your prediction for a PPS of $10.00 on April 1?

All The Best
John